Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a ...
Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.
11don MSN
Timing of hormone replacement therapy may influence Alzheimer's disease risk, study suggests
The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.
Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The trials were ...
In practice, clinicians should consider sex and hormonal status when evaluating and treating hypertension, Patel said. “While hormone-based therapies show potential, their effects on blood pressure ...
Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial The trials were conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback